Aurobindo Pharma Ltd.
|
HALFYEARLY RESULTS
|
|
You can view the
Halfyearly Results
for the last 5 years.
Market Cap. (Rs.)
|
63794.07 Cr.
|
P/BV
|
2.38
|
Book Value (Rs.)
|
458.07
|
52 Week High/Low (Rs.)
|
1177/505
|
FV/ML
|
1/1
|
P/E(X)
|
33.10
|
Bookclosure
|
20/02/2024
|
EPS (Rs.)
|
32.90
|
Div Yield (%)
|
0.28
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 13941.35 | 12766.64 | 11850.49 | 11784.77 | 11581.78 |
Other Operating Income | 128.59 | 113.45 | 124.80 | 26.82 | 62.12 |
Total Income From Operations | 14069.94 | 12880.09 | 11975.29 | 11811.59 | 11643.90 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 5465.74 | 5292.06 | 4360.45 | 3736.94 | 3634.89 |
Purchase of Traded Goods | 1211.23 | 1126.70 | 923.73 | 1133.24 | 818.53 |
Increase/Decrease in Stocks | -285.52 | -580.23 | 170.55 | 398.26 | 418.42 |
Employees Cost | 1906.94 | 1773.62 | 1748.63 | 1722.14 | 1728.78 |
Depreciation | 744.06 | 666.97 | 577.61 | 552.62 | 573.90 |
Other Expenses | 3216.95 | 3311.35 | 3044.66 | 2830.34 | 2647.18 |
Total Expenses | 12259.40 | 11590.47 | 10825.63 | 10373.54 | 9821.70 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 1810.54 | 1289.62 | 1149.66 | 1438.05 | 1822.20 |
Other Income | 273.52 | 227.56 | 97.81 | 113.87 | 206.48 |
P/L Before Interest, Excpt. Items & Tax | 2084.06 | 1517.18 | 1247.47 | 1551.92 | 2028.68 |
Interest | 124.73 | 100.56 | 39.92 | 25.34 | 23.30 |
P/L Before Exceptional Items & Tax | 1959.33 | 1416.62 | 1207.55 | 1526.58 | 2005.38 |
Exceptional Items | -69.75 | 0.00 | 0.00 | -127.97 | 0.00 |
P/L Before Tax | 1889.58 | 1416.62 | 1207.55 | 1398.61 | 2005.38 |
Tax | 566.02 | 413.25 | 271.60 | 206.98 | 518.65 |
P/L After Tax from Ordinary Activities | 1323.56 | 1003.37 | 935.95 | 1191.63 | 1486.73 |
Net Profit/Loss For the Period | 1323.56 | 1003.37 | 935.95 | 1191.63 | 1486.73 |
Minority Interest | 6.28 | 0.61 | -0.76 | 0.76 | 0.28 |
Share Of P/L Of Associates | -1.91 | -6.45 | -5.20 | -11.20 | -20.05 |
Net P/L After Minority Interest & Share Of Associates | 1327.93 | 997.53 | 929.99 | 1181.19 | 1466.96 |
| | | | | |
Equity Share Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
Reserves And Surplus | 0.00 | 0.00 | 25469.47 | 0.00 | 0.00 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 22.57 | 17.13 | 15.87 | 20.34 | 25.03 |
Diluted EPS (Rs.) | 22.57 | 17.13 | 15.87 | 20.34 | 25.03 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 22.57 | 17.13 | 15.87 | 20.34 | 25.03 |
Diluted EPS (Rs.) | 22.57 | 17.03 | 15.87 | 20.16 | 25.03 |
| | | | | |
PBITOE Margin (%) | 12.86 | 10.01 | 9.60 | 12.17 | 15.64 |
PBTE Margin (%) | 13.92 | 10.99 | 10.08 | 12.92 | 17.22 |
PBT Margin (%) | 13.42 | 10.99 | 10.08 | 11.84 | 17.22 |
PAT Margin (%) | 9.40 | 7.79 | 7.81 | 10.08 | 12.76 |
PAT After MI And SOA Margin (%) | 9.43 | 7.74 | 7.76 | 10.00 | 12.59 |